Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Flamel Technologies Inc.

Division of Avadel Pharmaceuticals PLC

Latest From Flamel Technologies Inc.

Keeping Track: Lilly's Olaratumab, Cempra's Solithromycin, AAA's Lutathera Complete Submissions; End Of The Road For Rociletinib

The latest drug development news and highlights from our FDA Performance Tracker.

BioPharmaceutical United States

Keeping Track: FDA Approves Two Novel Orphan Drugs; Breakthrough Applications Keep Agency Busy

The latest drug development news and highlights from our FDA Performance Tracker.

BioPharmaceutical Regulation
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Avadel Pharmaceuticals PLC
  • Senior Management
  • Contact Info
  • Flamel Technologies Inc.
    , VA
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register